Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
about
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted miceInotropes do not increase mortality in advanced heart failurebeta-blocker therapy: a standard of care for heart failure.Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogsRationale for the short term use of intravenous milrinone under hemodynamic guidance in patients with severe systolic heart failure.Outpatient dobutamine therapy: the rhyme and the riddle.Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricleTemporal Development of Autonomic Dysfunction in Heart Failure: Effects of Age in an Ovine Rapid-pacing ModelEffects of inotropic drugs on mechanical function and oxygen balance in postischemic canine myocardium: comparison of dobutamine, epinephrine, amrinone, and calcium chloride.Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion.Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: time to pace?Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
P2860
Q24650383-08D27E24-AF89-462C-8F42-3C936030FEACQ33685748-730255D6-E4AB-4EA3-BBA4-A26CADABCE22Q34088204-AE0BCC4C-B940-400E-8B31-A93603EB59D7Q34195979-8DDC967F-172D-4C83-9C67-AD88AE192D8CQ34766698-1F6B48E4-F95C-4F2E-B82C-3B26BBF6441EQ36244456-B9CBA341-BC1E-4074-B22C-788D948EC5F7Q37362141-8F074DFF-92FE-452C-80DF-BE7046698AFCQ37410498-5D00DDB0-DE5D-42C4-A744-C9845E4CD289Q37425657-25941037-C082-4C03-85CE-23391FAC3CFDQ44487188-24A99C36-4FBA-44A5-8D2A-124FADCA17D4Q46838656-3F300FD0-A760-4415-9938-D9B93F21CDF5Q54089909-A2C648EA-73BE-4C9C-B675-5A7011270617
P2860
Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Intracoronary infusion of dobu ...... phosphodiesterase inhibition.
@ast
Intracoronary infusion of dobu ...... phosphodiesterase inhibition.
@en
type
label
Intracoronary infusion of dobu ...... phosphodiesterase inhibition.
@ast
Intracoronary infusion of dobu ...... phosphodiesterase inhibition.
@en
prefLabel
Intracoronary infusion of dobu ...... phosphodiesterase inhibition.
@ast
Intracoronary infusion of dobu ...... phosphodiesterase inhibition.
@en
P2093
P2860
P356
P1476
Intracoronary infusion of dobu ...... phosphodiesterase inhibition.
@en
P2093
A R Denniss
D F Gauthier
G F Leatherman
P L Ludmer
W S Colucci
P2860
P304
P356
10.1172/JCI113423
P407
P577
1988-04-01T00:00:00Z